A start-up biotechnology research company had made significant headway in the development of a drug to improve quality and length of life for patients with terminal cancer. An established, leading pharmaceutical company recognized the tremendous potential of the drug and was interested in forming an alliance with the biotechnology company to deliver it to market. Both companies understood that it would take significant resources and time to

Join for free to read